AARTI DRUGS LTD
AARTI DRUGS LTD (India) holds 6 active US FDA Type II Drug Master Files and 11 inactive, has DMF or CEP filings on record for 20 active ingredients and is linked to 2 FDA-registered manufacturing sites. 2 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “AARTI DRUGS LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/aarti-drugs-ltd
Overview
AARTI DRUGS LTD is an active pharmaceutical ingredient (API) supplier with 6 active FDA Type II Drug Master Files, covering CELECOXIB; CIPROFLOXACIN HYDROCHLORIDE; NIACIN; RALOXIFENE HYDROCHLORIDE USP; RIVASTIGMINE HYDROGEN TARTRATE; ZOLPIDEM TARTRATE.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which AARTI DRUGS LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
AARTI DRUGS LTD holds 6 active (17 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- CELECOXIBActive2009-10-09
- RIVASTIGMINE HYDROGEN TARTRATEActive2009-07-31
- RALOXIFENE HYDROCHLORIDE USPActive2008-05-22
- NIACINActive2006-12-14
- CIPROFLOXACIN HYDROCHLORIDEActive2006-07-17
- ZOLPIDEM TARTRATEActive2006-05-16
- ROFECOXIBInactive2015-09-29
- PIOGLITAZONE HYDROCHLORIDEInactive2012-07-03
- DICLOFENAC EPOLAMINEInactive2012-04-03
- S (-) RIVASTIGMINE BASEInactive2009-04-01
- TICLOPIDINE HYDROCHLORIDEInactive2008-12-30
- HYDROXYZINE HYDROCHLORIDEInactive2008-10-06
- METFORMIN HYDROCHLORIDE USPInactive2008-02-01
- NIMESULIDEInactive2007-08-28
- LORATADINEInactive2007-04-30
- TERBINAFINE HYDROCHLORIDEInactive2006-09-13
- METOPROLOL SUCCINATEInactive2006-06-01
Registered manufacturing sites (2)
Physical sites registered with the US FDA and resolved to AARTI DRUGS LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
2 FDA enforcement records linked to this company.
- warning_letter2013-08-02
FDA Warning Letter (drug product)
- warning_letter2013-08-02
FDA Warning Letter (drug product)
Is this AARTI DRUGS LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.